Global Norovirus Diagnostics Market Growth (Status and Outlook) 2026-2032

September 2026 | 96 pages | ID: G09CCBE5957BEN
LP Information

Abstracts

The global Norovirus Diagnostics market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

Norovirus diagnostics refer to the methods and procedures used to identify the presence of norovirus in clinical samples, environmental samples, or food samples. Norovirus is a highly contagious virus that causes acute gastroenteritis in humans. It is a common cause of outbreaks of vomiting and diarrhea, particularly in settings such as cruise ships, healthcare facilities, and restaurants.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Norovirus Diagnostics Industry Forecast” looks at past sales and reviews total world Norovirus Diagnostics sales in 2025, providing a comprehensive analysis by region and market sector of projected Norovirus Diagnostics sales for 2026 through 2032. With Norovirus Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Norovirus Diagnostics industry.

This Insight Report provides a comprehensive analysis of the global Norovirus Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Norovirus Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Norovirus Diagnostics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Norovirus Diagnostics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Norovirus Diagnostics.

This report presents a comprehensive overview, market shares, and growth opportunities of Norovirus Diagnostics market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Rapid Test Kits
• PCR Kits
• ELISA Based Kits

Segmentation by Application:

• Hospitals
• Diagnostics Labs
• Clinics

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Abbott
• R-Biopharm
• ELITechGroup
• Danaher Corporation (Cepheid)
• Meridian Bioscience
• Eiken Chemical
• Altona Diagnostics
• CerTest Biotec
• Elisabeth Pharmacon
• Qiagen

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Norovirus Diagnostics Market Size (2021-2032)
  2.1.2 Norovirus Diagnostics Market Size CAGR by Region (2021 VS 2025 VS 2032)
  2.1.3 World Current & Future Analysis for Norovirus Diagnostics by Country/Region (2021, 2025 & 2032)
2.2 Norovirus Diagnostics Segment by Type
  2.2.1 Rapid Test Kits
  2.2.2 PCR Kits
  2.2.3 ELISA Based Kits
  2.2.4 Norovirus Diagnostics Market Size by Type
    2.2.4.1 Norovirus Diagnostics Market Size CAGR by Type (2021 VS 2025 VS 2032)
    2.2.4.2 Global Norovirus Diagnostics Market Size Market Share by Type (2021-2026)
2.3 Norovirus Diagnostics Segment by Application
  2.3.1 Hospitals
  2.3.2 Diagnostics Labs
  2.3.3 Clinics
  2.3.4 Norovirus Diagnostics Market Size by Application
    2.3.4.1 Norovirus Diagnostics Market Size CAGR by Application (2021 VS 2025 VS 2032)
    2.3.4.2 Global Norovirus Diagnostics Market Size Market Share by Application (2021-2026)

3 NOROVIRUS DIAGNOSTICS MARKET SIZE BY PLAYER

3.1 Norovirus Diagnostics Market Size Market Share by Player
  3.1.1 Global Norovirus Diagnostics Revenue by Player (2021-2026)
  3.1.2 Global Norovirus Diagnostics Revenue Market Share by Player (2021-2026)
3.2 Global Norovirus Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 NOROVIRUS DIAGNOSTICS BY REGION

4.1 Norovirus Diagnostics Market Size by Region (2021-2026)
4.2 Global Norovirus Diagnostics Annual Revenue by Country/Region (2021-2026)
4.3 Americas Norovirus Diagnostics Market Size Growth (2021-2026)
4.4 APAC Norovirus Diagnostics Market Size Growth (2021-2026)
4.5 Europe Norovirus Diagnostics Market Size Growth (2021-2026)
4.6 Middle East & Africa Norovirus Diagnostics Market Size Growth (2021-2026)

5 AMERICAS

5.1 Americas Norovirus Diagnostics Market Size by Country (2021-2026)
5.2 Americas Norovirus Diagnostics Market Size by Type (2021-2026)
5.3 Americas Norovirus Diagnostics Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Norovirus Diagnostics Market Size by Region (2021-2026)
6.2 APAC Norovirus Diagnostics Market Size by Type (2021-2026)
6.3 APAC Norovirus Diagnostics Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Norovirus Diagnostics Market Size by Country (2021-2026)
7.2 Europe Norovirus Diagnostics Market Size by Type (2021-2026)
7.3 Europe Norovirus Diagnostics Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Norovirus Diagnostics by Region (2021-2026)
8.2 Middle East & Africa Norovirus Diagnostics Market Size by Type (2021-2026)
8.3 Middle East & Africa Norovirus Diagnostics Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL NOROVIRUS DIAGNOSTICS MARKET FORECAST

10.1 Global Norovirus Diagnostics Forecast by Region (2027-2032)
  10.1.1 Global Norovirus Diagnostics Forecast by Region (2027-2032)
  10.1.2 Americas Norovirus Diagnostics Forecast
  10.1.3 APAC Norovirus Diagnostics Forecast
  10.1.4 Europe Norovirus Diagnostics Forecast
  10.1.5 Middle East & Africa Norovirus Diagnostics Forecast
10.2 Americas Norovirus Diagnostics Forecast by Country (2027-2032)
  10.2.1 United States Market Norovirus Diagnostics Forecast
  10.2.2 Canada Market Norovirus Diagnostics Forecast
  10.2.3 Mexico Market Norovirus Diagnostics Forecast
  10.2.4 Brazil Market Norovirus Diagnostics Forecast
10.3 APAC Norovirus Diagnostics Forecast by Region (2027-2032)
  10.3.1 China Norovirus Diagnostics Market Forecast
  10.3.2 Japan Market Norovirus Diagnostics Forecast
  10.3.3 Korea Market Norovirus Diagnostics Forecast
  10.3.4 Southeast Asia Market Norovirus Diagnostics Forecast
  10.3.5 India Market Norovirus Diagnostics Forecast
  10.3.6 Australia Market Norovirus Diagnostics Forecast
10.4 Europe Norovirus Diagnostics Forecast by Country (2027-2032)
  10.4.1 Germany Market Norovirus Diagnostics Forecast
  10.4.2 France Market Norovirus Diagnostics Forecast
  10.4.3 UK Market Norovirus Diagnostics Forecast
  10.4.4 Italy Market Norovirus Diagnostics Forecast
  10.4.5 Russia Market Norovirus Diagnostics Forecast
10.5 Middle East & Africa Norovirus Diagnostics Forecast by Region (2027-2032)
  10.5.1 Egypt Market Norovirus Diagnostics Forecast
  10.5.2 South Africa Market Norovirus Diagnostics Forecast
  10.5.3 Israel Market Norovirus Diagnostics Forecast
  10.5.4 Turkey Market Norovirus Diagnostics Forecast
10.6 Global Norovirus Diagnostics Forecast by Type (2027-2032)
10.7 Global Norovirus Diagnostics Forecast by Application (2027-2032)
  10.7.1 GCC Countries Market Norovirus Diagnostics Forecast

11 KEY PLAYERS ANALYSIS

11.1 Abbott
  11.1.1 Abbott Company Information
  11.1.2 Abbott Norovirus Diagnostics Product Offered
  11.1.3 Abbott Norovirus Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
  11.1.4 Abbott Main Business Overview
  11.1.5 Abbott Latest Developments
11.2 R-Biopharm
  11.2.1 R-Biopharm Company Information
  11.2.2 R-Biopharm Norovirus Diagnostics Product Offered
  11.2.3 R-Biopharm Norovirus Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
  11.2.4 R-Biopharm Main Business Overview
  11.2.5 R-Biopharm Latest Developments
11.3 ELITechGroup
  11.3.1 ELITechGroup Company Information
  11.3.2 ELITechGroup Norovirus Diagnostics Product Offered
  11.3.3 ELITechGroup Norovirus Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
  11.3.4 ELITechGroup Main Business Overview
  11.3.5 ELITechGroup Latest Developments
11.4 Danaher Corporation (Cepheid)
  11.4.1 Danaher Corporation (Cepheid) Company Information
  11.4.2 Danaher Corporation (Cepheid) Norovirus Diagnostics Product Offered
  11.4.3 Danaher Corporation (Cepheid) Norovirus Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
  11.4.4 Danaher Corporation (Cepheid) Main Business Overview
  11.4.5 Danaher Corporation (Cepheid) Latest Developments
11.5 Meridian Bioscience
  11.5.1 Meridian Bioscience Company Information
  11.5.2 Meridian Bioscience Norovirus Diagnostics Product Offered
  11.5.3 Meridian Bioscience Norovirus Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
  11.5.4 Meridian Bioscience Main Business Overview
  11.5.5 Meridian Bioscience Latest Developments
11.6 Eiken Chemical
  11.6.1 Eiken Chemical Company Information
  11.6.2 Eiken Chemical Norovirus Diagnostics Product Offered
  11.6.3 Eiken Chemical Norovirus Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
  11.6.4 Eiken Chemical Main Business Overview
  11.6.5 Eiken Chemical Latest Developments
11.7 Altona Diagnostics
  11.7.1 Altona Diagnostics Company Information
  11.7.2 Altona Diagnostics Norovirus Diagnostics Product Offered
  11.7.3 Altona Diagnostics Norovirus Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
  11.7.4 Altona Diagnostics Main Business Overview
  11.7.5 Altona Diagnostics Latest Developments
11.8 CerTest Biotec
  11.8.1 CerTest Biotec Company Information
  11.8.2 CerTest Biotec Norovirus Diagnostics Product Offered
  11.8.3 CerTest Biotec Norovirus Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
  11.8.4 CerTest Biotec Main Business Overview
  11.8.5 CerTest Biotec Latest Developments
11.9 Elisabeth Pharmacon
  11.9.1 Elisabeth Pharmacon Company Information
  11.9.2 Elisabeth Pharmacon Norovirus Diagnostics Product Offered
  11.9.3 Elisabeth Pharmacon Norovirus Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
  11.9.4 Elisabeth Pharmacon Main Business Overview
  11.9.5 Elisabeth Pharmacon Latest Developments
11.10 Qiagen
  11.10.1 Qiagen Company Information
  11.10.2 Qiagen Norovirus Diagnostics Product Offered
  11.10.3 Qiagen Norovirus Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
  11.10.4 Qiagen Main Business Overview
  11.10.5 Qiagen Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Norovirus Diagnostics Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Norovirus Diagnostics Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Rapid Test Kits
Table 4. Major Players of PCR Kits
Table 5. Major Players of ELISA Based Kits
Table 6. Norovirus Diagnostics Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Norovirus Diagnostics Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Norovirus Diagnostics Market Size Market Share by Type (2021-2026)
Table 9. Norovirus Diagnostics Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global Norovirus Diagnostics Market Size by Application (2021-2026) & ($ millions)
Table 11. Global Norovirus Diagnostics Market Size Market Share by Application (2021-2026)
Table 12. Global Norovirus Diagnostics Revenue by Player (2021-2026) & ($ millions)
Table 13. Global Norovirus Diagnostics Revenue Market Share by Player (2021-2026)
Table 14. Norovirus Diagnostics Key Players Head office and Products Offered
Table 15. Norovirus Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Norovirus Diagnostics Market Size by Region (2021-2026) & ($ millions)
Table 19. Global Norovirus Diagnostics Market Size Market Share by Region (2021-2026)
Table 20. Global Norovirus Diagnostics Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global Norovirus Diagnostics Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas Norovirus Diagnostics Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas Norovirus Diagnostics Market Size Market Share by Country (2021-2026)
Table 24. Americas Norovirus Diagnostics Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas Norovirus Diagnostics Market Size Market Share by Type (2021-2026)
Table 26. Americas Norovirus Diagnostics Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas Norovirus Diagnostics Market Size Market Share by Application (2021-2026)
Table 28. APAC Norovirus Diagnostics Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC Norovirus Diagnostics Market Size Market Share by Region (2021-2026)
Table 30. APAC Norovirus Diagnostics Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC Norovirus Diagnostics Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe Norovirus Diagnostics Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe Norovirus Diagnostics Market Size Market Share by Country (2021-2026)
Table 34. Europe Norovirus Diagnostics Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe Norovirus Diagnostics Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa Norovirus Diagnostics Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa Norovirus Diagnostics Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa Norovirus Diagnostics Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Norovirus Diagnostics
Table 40. Key Market Challenges & Risks of Norovirus Diagnostics
Table 41. Key Industry Trends of Norovirus Diagnostics
Table 42. Global Norovirus Diagnostics Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global Norovirus Diagnostics Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global Norovirus Diagnostics Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global Norovirus Diagnostics Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. Abbott Details, Company Type, Norovirus Diagnostics Area Served and Its Competitors
Table 47. Abbott Norovirus Diagnostics Product Offered
Table 48. Abbott Norovirus Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. Abbott Main Business
Table 50. Abbott Latest Developments
Table 51. R-Biopharm Details, Company Type, Norovirus Diagnostics Area Served and Its Competitors
Table 52. R-Biopharm Norovirus Diagnostics Product Offered
Table 53. R-Biopharm Norovirus Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. R-Biopharm Main Business
Table 55. R-Biopharm Latest Developments
Table 56. ELITechGroup Details, Company Type, Norovirus Diagnostics Area Served and Its Competitors
Table 57. ELITechGroup Norovirus Diagnostics Product Offered
Table 58. ELITechGroup Norovirus Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. ELITechGroup Main Business
Table 60. ELITechGroup Latest Developments
Table 61. Danaher Corporation (Cepheid) Details, Company Type, Norovirus Diagnostics Area Served and Its Competitors
Table 62. Danaher Corporation (Cepheid) Norovirus Diagnostics Product Offered
Table 63. Danaher Corporation (Cepheid) Norovirus Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Danaher Corporation (Cepheid) Main Business
Table 65. Danaher Corporation (Cepheid) Latest Developments
Table 66. Meridian Bioscience Details, Company Type, Norovirus Diagnostics Area Served and Its Competitors
Table 67. Meridian Bioscience Norovirus Diagnostics Product Offered
Table 68. Meridian Bioscience Norovirus Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Meridian Bioscience Main Business
Table 70. Meridian Bioscience Latest Developments
Table 71. Eiken Chemical Details, Company Type, Norovirus Diagnostics Area Served and Its Competitors
Table 72. Eiken Chemical Norovirus Diagnostics Product Offered
Table 73. Eiken Chemical Norovirus Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Eiken Chemical Main Business
Table 75. Eiken Chemical Latest Developments
Table 76. Altona Diagnostics Details, Company Type, Norovirus Diagnostics Area Served and Its Competitors
Table 77. Altona Diagnostics Norovirus Diagnostics Product Offered
Table 78. Altona Diagnostics Norovirus Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Altona Diagnostics Main Business
Table 80. Altona Diagnostics Latest Developments
Table 81. CerTest Biotec Details, Company Type, Norovirus Diagnostics Area Served and Its Competitors
Table 82. CerTest Biotec Norovirus Diagnostics Product Offered
Table 83. CerTest Biotec Norovirus Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. CerTest Biotec Main Business
Table 85. CerTest Biotec Latest Developments
Table 86. Elisabeth Pharmacon Details, Company Type, Norovirus Diagnostics Area Served and Its Competitors
Table 87. Elisabeth Pharmacon Norovirus Diagnostics Product Offered
Table 88. Elisabeth Pharmacon Norovirus Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. Elisabeth Pharmacon Main Business
Table 90. Elisabeth Pharmacon Latest Developments
Table 91. Qiagen Details, Company Type, Norovirus Diagnostics Area Served and Its Competitors
Table 92. Qiagen Norovirus Diagnostics Product Offered
Table 93. Qiagen Norovirus Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. Qiagen Main Business
Table 95. Qiagen Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Norovirus Diagnostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Norovirus Diagnostics Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Norovirus Diagnostics Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Norovirus Diagnostics Sales Market Share by Country/Region (2025)
Figure 8. Norovirus Diagnostics Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Norovirus Diagnostics Market Size Market Share by Type in 2025
Figure 10. Norovirus Diagnostics in Hospitals
Figure 11. Global Norovirus Diagnostics Market: Hospitals (2021-2026) & ($ millions)
Figure 12. Norovirus Diagnostics in Diagnostics Labs
Figure 13. Global Norovirus Diagnostics Market: Diagnostics Labs (2021-2026) & ($ millions)
Figure 14. Norovirus Diagnostics in Clinics
Figure 15. Global Norovirus Diagnostics Market: Clinics (2021-2026) & ($ millions)
Figure 16. Global Norovirus Diagnostics Market Size Market Share by Application in 2025
Figure 17. Global Norovirus Diagnostics Revenue Market Share by Player in 2025
Figure 18. Global Norovirus Diagnostics Market Size Market Share by Region (2021-2026)
Figure 19. Americas Norovirus Diagnostics Market Size 2021-2026 ($ millions)
Figure 20. APAC Norovirus Diagnostics Market Size 2021-2026 ($ millions)
Figure 21. Europe Norovirus Diagnostics Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Norovirus Diagnostics Market Size 2021-2026 ($ millions)
Figure 23. Americas Norovirus Diagnostics Value Market Share by Country in 2025
Figure 24. United States Norovirus Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Norovirus Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Norovirus Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Norovirus Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Norovirus Diagnostics Market Size Market Share by Region in 2025
Figure 29. APAC Norovirus Diagnostics Market Size Market Share by Type (2021-2026)
Figure 30. APAC Norovirus Diagnostics Market Size Market Share by Application (2021-2026)
Figure 31. China Norovirus Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Norovirus Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Norovirus Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Norovirus Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 35. India Norovirus Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Norovirus Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Norovirus Diagnostics Market Size Market Share by Country in 2025
Figure 38. Europe Norovirus Diagnostics Market Size Market Share by Type (2021-2026)
Figure 39. Europe Norovirus Diagnostics Market Size Market Share by Application (2021-2026)
Figure 40. Germany Norovirus Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 41. France Norovirus Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Norovirus Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Norovirus Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Norovirus Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Norovirus Diagnostics Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Norovirus Diagnostics Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Norovirus Diagnostics Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Norovirus Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Norovirus Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Norovirus Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Norovirus Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Norovirus Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Norovirus Diagnostics Market Size 2027-2032 ($ millions)
Figure 54. APAC Norovirus Diagnostics Market Size 2027-2032 ($ millions)
Figure 55. Europe Norovirus Diagnostics Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Norovirus Diagnostics Market Size 2027-2032 ($ millions)
Figure 57. United States Norovirus Diagnostics Market Size 2027-2032 ($ millions)
Figure 58. Canada Norovirus Diagnostics Market Size 2027-2032 ($ millions)
Figure 59. Mexico Norovirus Diagnostics Market Size 2027-2032 ($ millions)
Figure 60. Brazil Norovirus Diagnostics Market Size 2027-2032 ($ millions)
Figure 61. China Norovirus Diagnostics Market Size 2027-2032 ($ millions)
Figure 62. Japan Norovirus Diagnostics Market Size 2027-2032 ($ millions)
Figure 63. Korea Norovirus Diagnostics Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Norovirus Diagnostics Market Size 2027-2032 ($ millions)
Figure 65. India Norovirus Diagnostics Market Size 2027-2032 ($ millions)
Figure 66. Australia Norovirus Diagnostics Market Size 2027-2032 ($ millions)
Figure 67. Germany Norovirus Diagnostics Market Size 2027-2032 ($ millions)
Figure 68. France Norovirus Diagnostics Market Size 2027-2032 ($ millions)
Figure 69. UK Norovirus Diagnostics Market Size 2027-2032 ($ millions)
Figure 70. Italy Norovirus Diagnostics Market Size 2027-2032 ($ millions)
Figure 71. Russia Norovirus Diagnostics Market Size 2027-2032 ($ millions)
Figure 72. Egypt Norovirus Diagnostics Market Size 2027-2032 ($ millions)
Figure 73. South Africa Norovirus Diagnostics Market Size 2027-2032 ($ millions)
Figure 74. Israel Norovirus Diagnostics Market Size 2027-2032 ($ millions)
Figure 75. Turkey Norovirus Diagnostics Market Size 2027-2032 ($ millions)
Figure 76. Global Norovirus Diagnostics Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Norovirus Diagnostics Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Norovirus Diagnostics Market Size 2027-2032 ($ millions)